To unlock this feature and to subscribe to our weekly evidence emails, please create a FREE orthoEvidence account.

SIGNUP

Already Have an Account?

Loading...
Visit our Evidence-Based Covid-19 Website and Stay Up to Date with the latest Research.
Ace Report Cover

Nabilone well-tolerated, but weaker analgesic than dihydrocodeine for neuropathic pain

Download
Share
Reprints
Cite This
About
+ Favorites
Share
Reprints
Cite This
About
+ Favorites
Ace Report Cover
October 2018

Nabilone well-tolerated, but weaker analgesic than dihydrocodeine for neuropathic pain

Vol: 7| Issue: 10| Number:8| ISSN#: 2564-2537
Study Type:Therapy
OE Level Evidence:2
Journal Level of Evidence:N/A

Comparison of analgesic effects and patient tolerability of nabilone and dihydrocodeine for chronic neuropathic pain: Randomised, crossover, double blind study

BMJ. 2008 26-Jan;336(7637):199-201. http://dx.doi.org/10.1136/bmj.39429.619653.80

Contributing Authors:
MG Serpell B Frank J Hughes JNS Matthews D Kapur

Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here

Synopsis

96 patients with chronic neuropathic pain received increasing doses of nabilone and dihydrocodeine for 6-week periods in random order with a 2-week washout period. The purpose of the study was to compare the effect of nabilone on pain, quality of life (SF-36), and adverse events to that of dihydrocodeine. The results indicated that dihydrocodeine provided better analgesic effect, SF-36 scores for ...

CME Image

Did you know that you’re eligible to earn 0.5 CME credits for reading this report!

LEARN MORE

Join the Conversation

Please Login or Join to leave comments.

Learn about our AI Driven
High Impact Search Feature

High Impact Icon

Our AI driven High Impact metric calculates the impact an article will have by considering both the publishing journal and the content of the article itself. Built using the latest advances in natural language processing, OE High Impact predicts an article’s future number of citations better than impact factor alone.

Continue